Jenburkt Pharma standalone Jun-2018 sales at Rs 23.26 crore
Jenburkt Pharma has reported a sales total income from operations of Rs 23.26 crore and a net profit of Rs 2.70 crore for the quarter ended Jun-2018
July 31, 2018 / 16:42 IST
| Jenburkt Pharma has reported a standalone total income from operations of Rs 23.26 crore and a net profit of Rs 2.70 crore for the quarter ended Jun-2018. | | For the quarter ended Jun 2017 the standalone total income from operations was Rs 16.99 crore and net loss was Rs 2.88 crore. | | Jenburkt Pharma shares closed at 481.85 on January 31, 2017 (BSE) and has given -16.35% returns over the last 6 months and -4.35% over the last 12 months. |
|
| Jenburkt Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'18 | Mar'18 | Jun'17 | | Net Sales/Income from operations | 23.26 | 30.06 | 16.99 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 23.26 | 30.06 | 16.99 | | EXPENDITURE | | Consumption of Raw Materials | 2.49 | 3.37 | 1.89 | | Purchase of Traded Goods | 5.69 | 7.58 | 4.79 | | Increase/Decrease in Stocks | -1.08 | 0.53 | -0.35 | | Power & Fuel | -- | -- | -- | | Employees Cost | 7.79 | 7.40 | 6.45 | | Depreciation | 0.32 | 0.38 | 0.36 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 5.77 | 2.67 | 7.79 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 2.29 | 8.12 | -3.94 | | Other Income | 0.91 | 0.65 | 1.11 | | P/L Before Int., Excpt. Items & Tax | 3.19 | 8.77 | -2.82 | | Interest | 0.09 | 0.13 | 0.09 | | P/L Before Exceptional Items & Tax | 3.10 | 8.65 | -2.91 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 3.10 | 8.65 | -2.91 | | Tax | 0.41 | 3.07 | -0.03 | | P/L After Tax from Ordinary Activities | 2.70 | 5.58 | -2.88 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 2.70 | 5.58 | -2.88 | | Equity Share Capital | 4.59 | 4.59 | 4.65 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 5.88 | 12.15 | -6.19 | | Diluted EPS | 5.88 | 12.15 | -6.19 | | EPS After Extra Ordinary | | Basic EPS | 5.88 | 12.15 | -6.19 | | Diluted EPS | 5.88 | 12.15 | -6.19 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
